Deeper Knowledge, Faster

  • Plan your formulary budget
  • Find suppliers and generic API sources
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
US Department of Justice
Chinese Patent Office
US Army
Argus Health

Generated: June 28, 2017

DrugPatentWatch Database Preview

Dexamethasone sodium phosphate - Generic Drug Details

« Back to Dashboard

What are the generic sources for dexamethasone sodium phosphate and what is the scope of dexamethasone sodium phosphate patent protection?

Dexamethasone sodium phosphate
is the generic ingredient in thirteen branded drugs marketed by Mylan Labs Ltd, Watson Labs, West-ward Pharms Int, Ucb Inc, Fresenius Kabi Usa, Intl Medication, Teva Parenteral, Pharmafair, Luitpold, Wyeth Ayerst, Cent Pharms, Alcon, Abraxis Pharm, Bel Mar, Akorn, Dell Labs, Lyphomed, Bausch And Lomb, Sola Barnes Hind, Merck, Sandoz Inc, Aurobindo Pharma Ltd, Organon Usa Inc, and Alcon Pharms Ltd, and is included in forty-seven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-nine drug master file entries for dexamethasone sodium phosphate. Twenty-two suppliers are listed for this compound.

Summary for Generic Name: dexamethasone sodium phosphate

Drug Master File Entries: see list39
Suppliers / Packagers: see list22
Bulk Api Vendors: see list71
Clinical Trials: see list4,890
Patent Applications: see list5,038
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:dexamethasone sodium phosphate at DailyMed

Pharmacology for Ingredient: dexamethasone sodium phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
dexamethasone sodium phosphate
OINTMENT;OPHTHALMIC011977-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
dexamethasone sodium phosphate
INJECTABLE;INJECTION087065-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Organon Usa Inc
dexamethasone sodium phosphate
INJECTABLE;INJECTION014694-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
dexamethasone sodium phosphate
INJECTABLE;INJECTION088469-001Jan 25, 1984DISCNNoNo► Subscribe► Subscribe
dexamethasone sodium phosphate
SOLUTION/DROPS;OPHTHALMIC, OTIC011984-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Federal Trade Commission
Chinese Patent Office
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus